Stable Isotope Labeled Tafasitamab Biosimilar – Anti-CD19 mAb – Research Grade

Reference: PX-TA1365-SIL-1MG
Product nameStable Isotope Labeled Tafasitamab Biosimilar - Anti-CD19 mAb - Research Grade
SourceCAS 1422527-84-1
SpeciesHumanized
Expression systemMammalian cells
Purity>95%
BufferPBS buffer PH7.5
Delivery conditionBlue Ice
Delivery Time3-5 days if in stock; 5-8 weeks if production needed
Storage condition4°C for short term; -20°C for long term
BrandProteoGenix
Aliases /SynonymsMOR-00208,MOR-208,XENP-5574,XMP-5574,XmAb-5574,Xmab-CD19
ReferencePX-TA1365-SIL
Related ProductsPX-P4004
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-G2-kappa
ClonalityMonoclonal Antibody
SourceCAS 1422527-84-1
FormatLyophilized
LabellingArginine: 13C6,15N4 ; Lysine: 13C6,15N2
Isotopic Enrichment99%
Stability1 year

General information on Anti-CD19[Homo sapiens] (Tafasitamab) Monoclonal Antibody

Tafasitamab is a humanized monoclonal antibody that targets CD19. It is used for the treatment of B-cell malignancies. The CD19 surface protein is highly expressed on the surface of B-cells where it enhances B-cell receptor signaling. CD19 is especially expressed in cases of chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), diffuse large B-cell lymphoma (DLBCL). By its activity, tafasatimab induces the lysis of B-cells.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Stable Isotope Labeled Tafasitamab Biosimilar – Anti-CD19 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Tumor necrosis factor receptor superfamily member 6(FAS) (Gln26-Asn173)
Antigen Tumor necrosis factor receptor superfamily member 6(FAS) (Gln26-Asn173) PX-P4778 108€
Human IgG1 LALA Isotype Control antibody (HyHEL-10)
Isotype Control Human IgG1 LALA Isotype Control antibody (HyHEL-10) PTX17885-100 180€
Stable Isotope Labeled Tafasitamab Biosimilar – Anti-CD19 mAb – Research Grade
Biosimilar Stable Isotope Labeled Tafasitamab Biosimilar – Anti-CD19 mAb – Research Grade PX-TA1365-SIL 1500€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.